| 刘玉琴,赵凤菊,陈万青.中国2009年白血病发病和死亡资料分析[J].中国肿瘤,2013,22(7):528-534. |
| 中国2009年白血病发病和死亡资料分析 |
| An Analysis of Incidence and Mortality of Leukemia in China，2009 |
| 投稿时间：2013-05-13 |
| DOI：10.11735/j.issn.1004-0242.2013.07.A003 |
|
 |
| 中文关键词: 肿瘤登记 白血病 发病率 死亡率 中国 |
| 英文关键词:cancer registry leukemia incidence mortality China |
| 基金项目: |
|
| 摘要点击次数: 3077 |
| 全文下载次数: 1149 |
| 中文摘要: |
| 摘 要：［目的］ 评估中国肿瘤登记地区2009年白血病发病与死亡情况。［方法］按照全国肿瘤登记中心制定的审核方法和评价标准，对全国104个肿瘤登记处上报的2009年肿瘤登记数据进行评估，共72个登记处的数据入选，计算白血病发病率、死亡率、构成、累积率；人口标准化率根据全国1982年人口普查的人口结构和Segi’s 世界人口结构为标准。［结果］ 2009年72个登记地区共覆盖人口85 470 522人（其中城市57 489 009人，农村27 981 513人），白血病新发病例4 853例，死亡病例3 661例。白血病总体MV%为93.72%、DCO%为1.50%、M/I 比例为0.75，其中城市地区分别为94.38%、1.45%和0.71，农村地区分别为91.68%、1.68%和0.88。全国肿瘤登记地区白血病发病率为5.68/10万（男性6.35/10万，女性4.99/10万），中标率为4.34/10万，世标率为4.92/10万，累积率(0~74岁)为0.44%，占全部恶性肿瘤发病的1.99%；城市地区发病率为6.37/10万，中标率4.85/10万，世标率5.53/10万；农村地区发病率为4.25/10万，中标率为3.41/10万，世标率为3.76/10万。全国肿瘤登记地区白血病死亡率为4.28/10万（男性5.00/10万，女性3.55/10万），中标率为2.88/10万，世标率为3.35/10万，累积率(0~74岁)为0.31%，占全部恶性肿瘤死亡的2.37%；城市地区死亡率为4.56/10万，中标率2.91/10万，世标率3.43/10万；农村地区死亡率为3.72/10万，中标率2.82/10万，世标率3.14/10万。白血病发病率、死亡率均为城市高于农村，男性高于女性。髓样白血病发病率、死亡率远高于淋巴样白血病。［结论］ 积极开展白血病病因学研究，制定有效的干预措施，以期降低白血病发病率和死亡率。 |
| 英文摘要: |
| Abstract:［Purpose］ To evaluate incidence and mortality of leukemia in China in 2009. ［Methods］ On basis of the criteria of data quality from The National Central Cancer Registry (NCCR)，data from 104 registries were evaluated. There were 72 registries’ data qualified and accepted for cancer registry were annual report in 2009. Incidence and mortality stratified by areas (urban/rural)，sex，age group and cancer site were analyzed，and proportion and cumulative rate were calculated. Chinese population census in 1982 and Segi’s population were used for age-standardized incidence/mortality rates. ［Results］ All 72 cancer registries covered a total of 85 470 522 population (57 489 099 in urban and 27 981 513 in rural areas). The total new cases and deaths of leukemia were 4 853 and 3 661 respectively. The morphology verified cases accounted for 93.72%，death certification only cases accounted for 1.50%，and mortality to incidence ratio was 0.75. The crude incidence of leukemia in China cancer registration areas was 5.68/105(male 6.35/105，female 4.99/105)，age-standardized incidence rates by China standard population(ASR China) and by world standard population (ASR world) were 4.34/105 and 4.92/105 respectively，with the cumulative incidence rate (0～74 age years old) of 0.44%.The leukemia accounted for 1.99% of the total cancer incidence. The incidence，ASR China and ASR world of leukemia were 6.37/105，4.85/105 and 5.35/105 in urban areas，whereas 4.25/105，3.41/105 and 3.76/105 in rural areas respectively. The mortality of leukemia in China cancer registration areas was 4.28/105( 5.00/105 in male，3.35/105 in female)，age-standardized mortality rates by ASR China and by ASR world were 2.88/105 and 3.35/105 respectively，with the cumulative incidence rate(0～74 age years old) of 0.31%. The leukemia accounted for 2.37% of the total cancer mortality. The mortality，ASR China and ASR world of leukemia were 4.56/105， 2.91/105 and 3.43/105 in urban areas，whereas 3.72/105，2.82/105 and 3.14/105 in rural areas respectively. The incidence and mortality in urban were higher than those in rural，and the incidence and mortalility in men was higher than those in women.The incidence and mortality of myeloid leukemia was significantly higher than those of lymphoid leukemia. ［Conclusion］ Actively develop leukemia etiology research，make effective intervention measures，in order to reduce the incidence and mortality of leukemia. |
|
在线阅读
查看全文 查看/发表评论 下载PDF阅读器 |